share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Jorn

SEC announcement ·  Apr 18 04:20
Summary by Futu AI
Jorn Aldag, the Chief Executive Officer of HOOKIPA Pharma Inc. (ticker symbol: HOOK), was involved in a transaction with the company's shares on April 15, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within HOOKIPA Pharma and may influence their investment decisions.
Jorn Aldag, the Chief Executive Officer of HOOKIPA Pharma Inc. (ticker symbol: HOOK), was involved in a transaction with the company's shares on April 15, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within HOOKIPA Pharma and may influence their investment decisions.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.